参考文献/References:
[1].Rife E,Gedalia A. Kawasaki disease:an update[J]. Curr Rheumatol Rep,2020,22(10):75.
[2].Soni PR,Noval Rivas M,Arditi M. A comprehensive update on Kawasaki disease vasculitis and myocarditis[J]. Curr Rheumatol Rep,2020,22(2):6.
[3].中国医师协会儿科医师分会风湿免疫学组,樊志丹,俞海国,等. 中国儿童血管炎诊断与治疗系列专家共识之四——川崎病[J]. 中国实用儿科杂志,2023,38(7):481-488.
[4].黄国英. 川崎病流行病学研究进展和思考[J]. 中国小儿急救医学,2020,27(9):641-644.
[5].范雪,徐明国. 川崎病发病机制及治疗研究进展[J]. 中国实用儿科杂志,2021,36(5):339-344.
[6].蒋瑶,邢艳.中性粒细胞胞外诱捕网形成的分子机制研究进展[J]. 中国免疫学杂志,2022,38(10):1272-1277.
[7].Papayannopoulos V. Neutrophil extracellular traps in immunity and disease[J]. Nat Rev Immunol,2018,18(2):134-147.
[8].程怡,陈亚琳,相新新.中性粒细胞胞外诱捕网在相关疾病中的作用[J].生命的化学,2023,43(5):735-741.
[9].Denning NL,Aziz M,Gurien SD,et al. DAMPs and NETs in sepsis[J]. Front Immunol, 2019,10:2536.
[10].王瀚黎,田圆,梁群. 中性粒细胞胞外诱捕网在脓毒症中的作用机制与靶点[J]. 疑难病杂志,2022,21(11):1206-1210.
[11].Ebrahimi F,Giaglis S,Hahn S,et al. Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia:secondary analysis of a randomised controlled trial[J]. Eur Respir J,2018,51(4):1701389.
[12].俞灵盈.中性粒细胞胞外捕获网介导川崎病血管损伤的机制研究[D]. 贵州:遵义医科大学,2022.
[13].蔡泽波,韦明,贾高泉,等. 小儿川崎病EMPs、TNF-α、IL-6的水平变化及其与冠状动脉病变的关系[J]. 吉林医学,2022,43(4):922-925.
[14].Xu J,Zhang X,Pelayo R,et al. Extracellular histones are major mediators of death in sepsis[J]. Nat Med,2009,15(11):1318-1321.
[15].Blanco LP,Wang X,Carlucci PM,et al. RNA externalized by neutrophil extracellular traps promotes inflammatory pathways in endothelial cells[J]. Arthritis Rheumatol,2021,73(12):2282-2292.
[16].胡琳,杨艳娟,李洁滢,等. 红景天苷通过激活PI3K/Akt和抑制NF-κB信号通路改善川崎病冠状动脉损伤[J].实用医学杂志,2022,38(21):2657-2662,2669.
[17].Novotny J,Chandraratne S,Weinberger T,et al. Histological comparison of arterial thrombi in mice and men and the influence of Cl-amidine on thrombus formation[J]. PLoS One,2018,13(1):e0190728.
[18].陈丹,杨晓林,沈照波,等. 中性粒细胞胞外网状陷阱及相关标志物对儿童社区获得性肺炎诊断的价值[J]. 中国当代儿科杂志,2019,21(9):868-875.
[19].Fisher J,Mohanty T,Karlsson CAQ,et al. Proteome profiling of recombinant DNase therapy in reducing NETs and aiding recovery in COVID-19 patienst[J]. Mol Cell Proteomics,2021,20:100113.
[20].陕西省川崎病诊疗中心,陕西省儿童内科疾病临床医学研究中心,陕西省人民医院儿童病院,等. 静脉输注免疫球蛋白在儿童川崎病中应用的专家共识[J]. 中国当代儿科杂志,2021,23(9):867-876.
[21].高立超,龚方戚. 血小板-白细胞聚集体及其在川崎病发病中的研究进展[J]. 中国当代儿科杂志,2023(6):587-594.
[22].王瑞青,郑彩虹,朱巍,等.血小板微粒介导miR-4306调控糖尿病大鼠主动脉血管内皮细胞损伤的作用及机制研究[J].中国比较医学杂志,2021(9):105-112.
[23].Jakob A,Schachinger E,Klau S,et al. Von willebrand factor parameters as potential biomarkers for disease activity and coronary artery lesion in patients with Kawasaki disease[J]. Eur J Pediatr, 2020,179(3):377-384.
[24].蔡泽波,于力,韦明,等. 循环内皮细胞、内皮细胞微粒检测对不完全川崎病的辅助诊断价值[J]. 广东医学,2020,(16):1655-1658.
[25].Jin J,Wang J,Lu Y,et al. Platelet-derived microparticles:a new index of monitoring platelet activation and inflammation in Kawasaki disease[J]. Indian J Pediatr,2019,86(3):250-255.
相似文献/References:
[1]杨再英,王钰.川崎病后无创检查评估血管内皮功能的研究进展[J].心血管病学进展,2019,(6):939.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.025]
YANG Zaiying,WANG Yu.Non-invasive Assessment of Vascular Endothelial Function after Kawasaki Disease[J].Advances in Cardiovascular Diseases,2019,(11):939.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.025]
[2]石树文 田雯.肠道微生物群与儿童川崎病[J].心血管病学进展,2020,(6):608.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.012]
SHI ShuwenTIAN Wen. Intestinal microbiota and children Kawasaki disease[J].Advances in Cardiovascular Diseases,2020,(11):608.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.012]
[3]孙一博 孙莉萍 董建增.血管炎的冠状动脉风险及手术治疗进展[J].心血管病学进展,2020,(8):821.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.010]
SUN YiboSUN LipingDONG Jianzeng.Coronary Risk and Progress in Surgical Therapy of Vasculitis[J].Advances in Cardiovascular Diseases,2020,(11):821.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.010]
[4]魏伟 魏灵睿 冷辉.血清miR-1和miR-26水平与川崎病患儿的关系及其对冠状动脉损伤的评估价值[J].心血管病学进展,2021,(5):476.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.021]
WEI WeiWEI LingruiLENG Hui.Relationship Between Serum miR-1 and miR-26 Levels and Kawasaki Disease in Children and Its Value in Evaluating Coronary Artery Injury[J].Advances in Cardiovascular Diseases,2021,(11):476.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.021]
[5]王琼琼,赵胜.血小板活化在川崎病中的研究进展[J].心血管病学进展,2021,(6):552.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.000]
WANG QiongqiongZHAO Sheng.Platelet Activation in the Pathogenesis of Kawasaki Disease[J].Advances in Cardiovascular Diseases,2021,(11):552.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.000]
[6]李红霞 朱凯 刘雯 王慧 杨涛毅.0~5岁川崎病儿童静脉注射免疫球蛋白耐药的相关因素分析及预测模型构建[J].心血管病学进展,2023,(3):283.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.020]
LI HongxiaZHU KaiLIU WenWANG HuiYANG Taoyi?/html>.Analysis of Related Factors and Prediction Model?f Intravenous Immunoglobulin Resistance in Children with Kawasaki Disease Aged 0 5 Years[J].Advances in Cardiovascular Diseases,2023,(11):283.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.020]
[7]王慧 张燕平 王志强 陈桂华 谢江.基于孟德尔随机化探索肠道菌群与儿童川崎病之间的因果关系[J].心血管病学进展,2023,(6):572.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.020]
WANG HuiZHANG Yanping,WANG Zhiqiang,CHEN Guihua,et al.To Explore the Causal Relationship Between Gut Microbiota and Kawasaki Disease in Children Based on Mendelian Randomization[J].Advances in Cardiovascular Diseases,2023,(11):572.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.020]